Physician profile
Anu Gupta
NPI 1790780963
$845.58
in general payments reported to CMS, 2019-2025
13 companies · $44.88 in 2025
The $44.88 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $39.86 · 2020: $37.68 · 2021: $176 · 2022: $277 · 2023: $134 · 2024: $136 · 2025: $44.88.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $315.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $314.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elekta, INC. | $180.11 | 2021-2022 | |
| Teleflex LLC | $138.74 | 2022 | |
| Novartis Pharmaceuticals Corporation | $104.56 | 2022-2025 | |
| Boston Scientific Corporation | $101.34 | 2019-2023 | Spaceoar Vue System - 10ml |
| Myriad Genetic Laboratories, INC. | $67.82 | 2021-2023 | Prolaris |
| Astrazeneca Pharmaceuticals Lp | $62.64 | 2024 | Imfinzi, Tagrisso |
| Progenics Pharmaceuticals, INC. | $48.98 | 2023 | Pylarify |
| Telix Pharmaceuticals | $39.93 | 2024 | Illuccix |
| Janssen Biotech, INC. | $29.46 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.58 | 2022 | |
| Pfizer INC. | $18.34 | 2025 | |
| Merck Sharp & Dohme LLC | $17.51 | 2021 | |
| Blue Earth Diagnostics | $15.57 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anu Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.